Tumor organoid-T-cell coculture systems.
Tumor organoid-T-cell coculture systems.
复制标题
DOI:
10.1038/s41596-019-0232-9
复制
发表时间:
2020-01
期刊:
影响因子:
14.8
通讯作者:
Voest EE
中科院分区:
文献类型:
--
作者:
Cattaneo CM;Dijkstra KK;Fanchi LF;Kelderman S;Kaing S;van Rooij N;van den Brink S;Schumacher TN;Voest EE
T cells are a key player in cancer immunotherapy, but strategies to expand tumor-reactive cells and study their interaction with tumor cells at the level of an individual patient are limited. This protocol describes the generation and functional assessment of tumor-reactive T cells based on co-cultures of tumor organoids and autologous peripheral blood lymphocytes. The procedure consists of an initial co-culture of two weeks in which tumor-reactive T cells are first expanded in the presence of (IFNγ-stimulated) autologous tumor cells. Subsequently, T cells may be evaluated for their capacity to carry out effector functions (IFNγ secretion, degranulation) upon recognition of tumor cells, and their capacity to kill tumor organoids. This strategy is unique in its use of peripheral blood as a source of tumor-reactive T cells in an antigen-agnostic manner. In two weeks, tumor-reactive CD8+ T cell populations can be obtained for ~33-50% of non-small cell lung cancer (NSCLC) and microsatellite instable (MSI) colorectal cancer (CRC) patient samples. It thereby allows the establishment of ex vivo test systems for T cell-based immunotherapy at the level of the individual patient.
登录
查看更多内容
影响因子:
82.9
作者:
Gros A;Parkhurst MR;Tran E;Pasetto A;Robbins PF;Ilyas S;Prickett TD;Gartner JJ;Crystal JS;Roberts IM;Trebska-McGowan K;Wunderlich JR;Yang JC;Rosenberg SA
通讯作者:
Rosenberg SA
影响因子:
3.8
作者:
Tsai S;McOlash L;Palen K;Johnson B;Duris C;Yang Q;Dwinell MB;Hunt B;Evans DB;Gershan J;James MA
通讯作者:
James MA
影响因子:
56.9
作者:
Stronen, Erlend;Toebes, Mireille;Schumacher, Ton N.
通讯作者:
Schumacher, Ton N.
影响因子:
64.8
作者:
Simoni, Yannick;Becht, Etienne;Newell, Evan W.
通讯作者:
Newell, Evan W.
影响因子:
64.5
作者:
Neal, James T.;Li, Xingnan;Kuo, Calvin J.
通讯作者:
Kuo, Calvin J.